{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T11:42:49Z","timestamp":1774957369110,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12879-017-2898-3","type":"journal-article","created":{"date-parts":[[2017,12,28]],"date-time":"2017-12-28T00:34:36Z","timestamp":1514421276000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Comparison of line probe assay to BACTEC MGIT 960 system for susceptibility testing of first and second-line anti-tuberculosis drugs in a referral laboratory in South Africa"],"prefix":"10.1186","volume":"17","author":[{"given":"Nontuthuko E.","family":"Maningi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lesibana A.","family":"Malinga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John F.","family":"Antiabong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth M.","family":"Lekalakala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nontombi M.","family":"Mbelle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,12,28]]},"reference":[{"key":"2898_CR1","volume-title":"Global Tuberculosis Report 2016","author":"World Health Organization 2016","year":"2016","unstructured":"World Health Organization 2016. Global Tuberculosis Report 2016. Geneva: World Health Organization; 2016."},{"key":"2898_CR2","first-page":"564","volume":"3","author":"LB Heifets","year":"1999","unstructured":"Heifets LB, Cangelosi GA. Drug susceptibility testing of Mycobacterium tuberculosis: a neglected problem at the turn of the century [State of the Art]. Int J Tuberc Lung Dis. 1999;3:564\u201381.","journal-title":"Int J Tuberc Lung Dis"},{"key":"2898_CR3","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1128\/JCM.44.1.20-28.2006","volume":"44","author":"C Piersimoni","year":"2006","unstructured":"Piersimoni C, Olivieri A, Benacchio L, Scarparo C. Current perspectives on drug susceptibility testing of Mycobacterium tuberculosis complex: the automated nonradiometric systems. J Clin Microbiol. 2006;44:20\u20138.","journal-title":"J Clin Microbiol"},{"key":"2898_CR4","first-page":"307","volume":"32","author":"DG Altman","year":"1983","unstructured":"Altman DG, Bland JM. Measurement in medicine: the analysis of method comparison studies. Underst Stat. 1983;32:307\u201317.","journal-title":"Underst Stat"},{"key":"2898_CR5","doi-asserted-by":"crossref","first-page":"1601075","DOI":"10.1183\/13993003.01075-2016","volume":"49","author":"RR Nathavitharana","year":"2017","unstructured":"Nathavitharana RR, Cudahy PGT, Schumacher SG, Steingart KR, Pai M, Denkinger CM. Accuracy of line probe assays for the diagnosis of pulmonary and multidrug-resistant tuberculosis: a systematic review and meta-analysis. Eur Respir J. 2017;49:1601075.","journal-title":"Eur Respir J"},{"key":"2898_CR6","doi-asserted-by":"crossref","first-page":"90569","DOI":"10.1371\/journal.pone.0090569","volume":"9","author":"O Ocheretina","year":"2014","unstructured":"Ocheretina O, Escuyer VE, Mabou MM, Royal-Mardi G, Collins S, Vilbrun SC, et al. Correlation between genotypic and phenotypic testing for resistance to rifampin in Mycobacterium tuberculosis clinical isolates in Haiti: investigation of cases with discrepant susceptibility results. PLoS One. 2014;9:90569.","journal-title":"PLoS One"},{"key":"2898_CR7","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1128\/JCM.00417-14","volume":"52","author":"MA Yakrus","year":"2014","unstructured":"Yakrus MA, Driscoll J, Lentz AJ, Sikes D, Hartline D, Metchock B, Starks AM. Concordance between molecular and phenotypic testing of Mycobacterium tuberculosis complex isolates for resistance to rifampin and isoniazid in the United States. J Clin Microbiol. 2014;52:1932\u20137.","journal-title":"J Clin Microbiol"},{"key":"2898_CR8","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.3389\/fmicb.2016.01947","volume":"7","author":"I Rukasha","year":"2016","unstructured":"Rukasha I, Said HM, Omar SV, Koornhof H, Dreyer AW, Musekiwa A, Moultrie H, Hoosen AA, Kaplan G, Fallows D, Nazir IN. Correlation of rpoB mutations with minimal inhibitory concentration of Rifampin and Rifabutin in Mycobacterium tuberculosis in an HIV\/AIDS endemic setting, South Africa. Front Microbiol. 2016;7:1947.","journal-title":"Front Microbiol"},{"key":"2898_CR9","doi-asserted-by":"crossref","first-page":"230","DOI":"10.4103\/0255-0857.115625","volume":"31","author":"AK Maurya","year":"2013","unstructured":"Maurya AK, Singh AK, Kant S, Umrao J, Kumar M, Kushwaha RAS, Nag VL, Dhole TN. Use of GenoType\u00ae MTBDRplus assay to assess drug resistance and mutation patterns of multidrug-resistant tuberculosis isolates in northern India. Indian J Med Microbiol. 2013;31:230\u20136.","journal-title":"Indian J Med Microbiol"},{"key":"2898_CR10","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1128\/JCM.01209-09","volume":"47","author":"A Van Deun","year":"2009","unstructured":"Van Deun A, Barrera L, Bastian I, Fattorini L, Hoffmann H, Kam KM, Rigouts L, R\u00fcsch-Gerdes S, Wright A. Mycobacterium tuberculosis strains with highly discordant rifampin susceptibility test results. J Clin Microbiol. 2009;47:3501\u20136.","journal-title":"J Clin Microbiol"},{"issue":"3","key":"2898_CR11","first-page":"455","volume":"137","author":"SK Sharma","year":"2013","unstructured":"Sharma SK, Mohan A. Tuberculosis: from an incurable scourge to a curable disease - journey over a millennium. Indian J Med Res. 2013;137(3):455\u201393.","journal-title":"Indian J Med Res"},{"key":"2898_CR12","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1128\/JCM.05092-11","volume":"50","author":"Y Tan","year":"2012","unstructured":"Tan Y, Hu Z, Zhao Y, Cai X, Luo C, Zou C. The beginning of the rpoB gene in addition to the rifampin resistance determination region might be needed for identifying rifampin\/rifabutin cross-resistance in multidrug-resistant Mycobacterium tuberculosis isolates from southern China. J Clin Microbiol. 2012;50:81\u20135.","journal-title":"J Clin Microbiol"},{"key":"2898_CR13","doi-asserted-by":"crossref","first-page":"318","DOI":"10.4103\/0255-0857.136587","volume":"32","author":"N Kiraz","year":"2014","unstructured":"Kiraz N, Oz Y, Saglik I. Evaluation of the genotype MTBDR assay for detection of rifampicin and isoniazid resistance in Mycobacterium tuberculosis complex isolates. Ind J Med Microbiol. 2014;32:318\u201322.","journal-title":"Ind J Med Microbiol"},{"key":"2898_CR14","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1128\/JCM.00083-06","volume":"44","author":"P Miotto","year":"2006","unstructured":"Miotto P, Piana F, Penati V, Canducci F, Migliori GB, Cirillo DM. Use of genotype MTBDR assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis clinical strains isolated in Italy. J Clin Microbiol. 2006;44:2485\u201391.","journal-title":"J Clin Microbiol"},{"issue":"5","key":"2898_CR15","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1586\/17476348.2.5.583","volume":"2","author":"DI Ling","year":"2008","unstructured":"Ling DI, Zwerling AA, Pai M. Rapid diagnosis of drug-resistant TB using line probe assays: from evidence to policy. Expert Rev Respir Med. 2008;2(5):583\u20138.","journal-title":"Expert Rev Respir Med"},{"key":"2898_CR16","doi-asserted-by":"crossref","first-page":"11e77712","DOI":"10.1371\/journal.pone.0077712","volume":"8","author":"YM Coovadia","year":"2013","unstructured":"Coovadia YM, Mahomed S, Pillay M, Werner L, Mlisana K. Rifampicin mono-resistance in Mycobacterium tuberculosis in KwaZulu-Natal, South Africa: a significant phenomenon in a high prevalence TB-HIV region. PLoS One. 2013;8:11e77712.","journal-title":"PLoS One"},{"key":"2898_CR17","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1186\/1471-2334-14-442","volume":"14","author":"NR Dlamini-Mvelase","year":"2014","unstructured":"Dlamini-Mvelase NR, Werner L, Phili R, et al. Effects of introducing Xpert MTB\/RIF test on multi-drug resistant tuberculosis diagnosis in KwaZulu-Natal South Africa. BMC Infect Dis. 2014;14:442.","journal-title":"BMC Infect Dis"},{"key":"2898_CR18","doi-asserted-by":"crossref","first-page":"76","DOI":"10.5588\/ijtld.11.0360","volume":"16","author":"A Dramowski","year":"2012","unstructured":"Dramowski A, Morsheimer M, Jordaan A, Victor T, Donald P, et al. Rifampicin-monoresistant Mycobacterium tuberculosis disease among children in cape town, South Africa. Int J Tuberc Lung Dis. 2012;16:76\u201381.","journal-title":"Int J Tuberc Lung Dis"},{"key":"2898_CR19","doi-asserted-by":"crossref","first-page":"196","DOI":"10.5588\/ijtld.11.0116","volume":"16","author":"F Mukinda","year":"2012","unstructured":"Mukinda F, Theron D, Van Der Spuy G, Jacobson K, Roscher M, et al. Rise in rifampicin-monoresistant tuberculosis in western Cape, South Africa. The Int J Tuberc Lung Dis. 2012;16:196\u2013202.","journal-title":"The Int J Tuberc Lung Dis"},{"issue":"8","key":"2898_CR20","doi-asserted-by":"crossref","first-page":"e70919","DOI":"10.1371\/journal.pone.0070919","volume":"8","author":"B Muller","year":"2013","unstructured":"Muller B, Chihota VN, Pillay M, Klopper M, Streicher EM, Coetzee G, Trollip A, Hayes C, Bosman ME, van Pittius NCG, Victor TC, Gagneux S, van Helden PD, Warren RM. Programmatically selected multidrug-resistant strains drive the emergence of extensively drug-resistant tuberculosis in South Africa. PLoS One. 2013;8(8):e70919.","journal-title":"PLoS One"},{"key":"2898_CR21","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1128\/JCM.01947-09","volume":"48","author":"F Brossier","year":"2010","unstructured":"Brossier F, Veziris N, Aubry A, Jarlier V, Sougakoff W. Detection by GenoType MTBDRsl test of complex mechanisms of resistance to second-line drugs and ethambutol in multidrug-resistant Mycobacterium tuberculosis complex isolates. J Clin Microbiol. 2010;48:1683\u20139.","journal-title":"J Clin Microbiol"},{"key":"2898_CR22","volume-title":"Molecular line probe assays for rapid screening of patients at risk of multidrug-resistant tuberculosis (MDR-TB)","author":"WHO","year":"2008","unstructured":"WHO (2008) Molecular line probe assays for rapid screening of patients at risk of multidrug-resistant tuberculosis (MDR-TB). Policy statement WHO."},{"key":"2898_CR23","doi-asserted-by":"crossref","unstructured":"Zeng X, Jinga W, Zhang Y, Duan H, Huang H, Chu N. Performance of the MTBDRsl Line probe assay for rapid detection of resistance to second-line anti-tuberculosis drugs and ethambutol in China. Diagn Microbiol Infect Dis. 2017;89:112\u20137.","DOI":"10.1016\/j.diagmicrobio.2016.06.011"},{"key":"2898_CR24","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.tube.2016.08.002","volume":"101","author":"S Swaminatha","year":"2016","unstructured":"Swaminatha S, Sundaramurthi JC. Recent developments in genomics, bioinformatics and drug discovery to combat emerging drug-resistant tuberculosis. Tuberculosis. 2016;101:31\u201340.","journal-title":"Tuberculosis"},{"issue":"1","key":"2898_CR25","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1128\/JCM.02378-13","volume":"52","author":"S Banu","year":"2014","unstructured":"Banu S, Rahman SMM, Khan MSR, et al. Discordance across several methods for drug susceptibility testing of drug-resistant Mycobacterium tuberculosis isolates in a single laboratory. J Clin Microbiol. 2014;52(1):156\u201316313.","journal-title":"J Clin Microbiol"},{"issue":"3","key":"2898_CR26","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1128\/JCM.01865-16","volume":"55","author":"Y Gardee","year":"2017","unstructured":"Gardee Y, Dreyer AW, Koornhof HJ, Omar SV, da Silva P, Bhyat Z, Ismail NA. Evaluation of the GenoType MTBDRsl version 2.0 assay for second-line drug resistance detection of Mycobacterium tuberculosis isolates in South Africa. J Clin Microbiol. 2017;55(3):791\u2013800.","journal-title":"J Clin Microbiol"},{"key":"2898_CR27","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1128\/JCM.01257-15","volume":"53","author":"E Tagliani","year":"2015","unstructured":"Tagliani E, Cabibbe AM, Miotto P, Borroni E, Toro JC, Mansjo M, Hoffner S, Hillemann D, Zalutskaya A, Skrahina A, Cirillo DM. Diagnostic performance of the new version (v2.0) of GenoType MTBDRsl assay for detection of resistance to fluoroquinolones and second-line injectable drugs: a multicenter study. J Clin Microbiol. 2015;53:2961.","journal-title":"J Clin Microbiol"},{"key":"2898_CR28","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1128\/JCM.01938-07","volume":"46","author":"OJ Strauss","year":"2008","unstructured":"Strauss OJ, Warren RM, Jordaan A, Streicher EM, Hanekom M, Falmer A, et al. Spread of a low-fitness drug-resistant Mycobacterium tuberculosis strain in a setting of high human immunodeficiency virus prevalence. J Clin Microbiol. 2008;46:1514\u20136.","journal-title":"J Clin Microbiol"},{"key":"2898_CR29","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3201\/eid1903.120246","volume":"19","author":"M Klopper","year":"2013","unstructured":"Klopper M, Warren RM, Hayes C, Gey van Pittius NC, Streicher EM, M\u00fcller B, et al. Emergence and spread of extensively and totally drug-resistant tuberculosis, South Africa. Emerg Infect Dis. 2013;19:449\u201355.","journal-title":"Emerg Infect Dis"},{"key":"2898_CR30","first-page":"533","volume":"45","author":"X Mao","year":"2015","unstructured":"Mao X, Ke Z, Shi X, Liu S, Tang B, Wang J, Huang H. Diagnosis of drug resistance to fluoroquinolones, amikacin, capreomycin, kanamycin and ethambutol with genotype MTBDRsl assay: a meta-analysis. Ann Clin Lab Sci. 2015;45:533.","journal-title":"Ann Clin Lab Sci"},{"key":"2898_CR31","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s12879-017-2389-6","volume":"17","author":"A Meaza","year":"2017","unstructured":"Meaza A, Kebede A, Yaregal Z, Dagne Z, Moga S, Yenew B, Diriba G, Molalign H, Tadesse M, Adisse D, Getahun M, Desta K. Evaluation of genotype MTBDRplus VER 2.0 line probe assay for the detection of MDR-TB in smear positive and negative sputum samples. BMC Infect Dis. 2017;17:280.","journal-title":"BMC Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-017-2898-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,12,28]],"date-time":"2017-12-28T00:35:00Z","timestamp":1514421300000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-017-2898-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["2898"],"URL":"https:\/\/doi.org\/10.1186\/s12879-017-2898-3","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12]]},"article-number":"795"}}